Review



injection with enzalutamide  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 98
      Buy from Supplier

    Structured Review

    MedChemExpress injection with enzalutamide
    Injection With Enzalutamide, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 98/100, based on 278 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/injection+with+enzalutamide/Enzalutamide/pm41603134-255-17-24
    Average 98 stars, based on 278 article reviews
    injection with enzalutamide - by Bioz Stars, 2026-09
    98/100 stars

    Images

    Related Articles

    Drug discovery:

    Article Title: Cancer Cell-Intrinsic Cholesterol Induces Lipid-Associated Macrophage Differentiation via SP1 Palmitoylation to Promote Prostate Cancer Progression.
    Article Snippet: .. To evaluate combinatorial therapeutic efficacy, tumor-bearing mice were randomized ( n = 5) and treated via intraperitoneal injection with Enzalutamide (10 mg/kg daily; HY-70002, MCE) either alone or in combination with the following agents: Simvastatin (20 mg/kg daily; HY-17502, MCE), Terbinafine (30 mg/kg daily; HY-17395, MCE), or the MDK inhibitor iMDK (9 mg/kg daily; HY-110171, MCE). ..

    Article Title: Cancer Cell‐Intrinsic Cholesterol Induces Lipid‐Associated Macrophage Differentiation via SP1 Palmitoylation to Promote Prostate Cancer Progression
    Article Snippet: .. To evaluate combinatorial therapeutic efficacy, tumor‐bearing mice were randomized ( n = 5) and treated via intraperitoneal injection with Enzalutamide (10 mg/kg daily; HY‐70002, MCE) either alone or in combination with the following agents: Simvastatin (20 mg/kg daily; HY‐17502, MCE), Terbinafine (30 mg/kg daily; HY‐17395, MCE), or the MDK inhibitor iMDK (9 mg/kg daily; HY‐110171, MCE). ..

    Injection:

    Article Title: Cancer Cell-Intrinsic Cholesterol Induces Lipid-Associated Macrophage Differentiation via SP1 Palmitoylation to Promote Prostate Cancer Progression.
    Article Snippet: .. To evaluate combinatorial therapeutic efficacy, tumor-bearing mice were randomized ( n = 5) and treated via intraperitoneal injection with Enzalutamide (10 mg/kg daily; HY-70002, MCE) either alone or in combination with the following agents: Simvastatin (20 mg/kg daily; HY-17502, MCE), Terbinafine (30 mg/kg daily; HY-17395, MCE), or the MDK inhibitor iMDK (9 mg/kg daily; HY-110171, MCE). ..

    Article Title: Cancer Cell‐Intrinsic Cholesterol Induces Lipid‐Associated Macrophage Differentiation via SP1 Palmitoylation to Promote Prostate Cancer Progression
    Article Snippet: .. To evaluate combinatorial therapeutic efficacy, tumor‐bearing mice were randomized ( n = 5) and treated via intraperitoneal injection with Enzalutamide (10 mg/kg daily; HY‐70002, MCE) either alone or in combination with the following agents: Simvastatin (20 mg/kg daily; HY‐17502, MCE), Terbinafine (30 mg/kg daily; HY‐17395, MCE), or the MDK inhibitor iMDK (9 mg/kg daily; HY‐110171, MCE). ..



    Similar Products

    injection with enzalutamide  (MedChemExpress)
    98
    MedChemExpress injection with enzalutamide
    Injection With Enzalutamide, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/injection+with+enzalutamide/Enzalutamide/pm41603134-255-17-24
    Average 98 stars, based on 1 article reviews
    injection with enzalutamide - by Bioz Stars, 2026-09
    98/100 stars
    		  Buy from Supplier

    Image Search Results